<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Toad Venom, called chansu (CS) in China, is an <z:chebi fb="0" ids="35472">anti-inflammatory drug</z:chebi> used in small doses for the treatment of various types of <z:mp ids='MP_0001845'>inflammation</z:mp> in China </plain></SENT>
<SENT sid="1" pm="."><plain>Its use is hampered by the cardiotoxicity of bufadienolides derived from Toad Venom </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C1321581" disease_type="Disease or Syndrome" abbrv="">Bezoar</z:e> Bovis is another frequently used drug in Toad Venom preparations for the treatment of inflammatory or <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> in Asia </plain></SENT>
<SENT sid="3" pm="."><plain>We explored whether <z:e sem="disease" ids="C1321581" disease_type="Disease or Syndrome" abbrv="">Bezoar</z:e> Bovis could protect against CS-induced <z:hpo ids='HP_0011009'>acute</z:hpo> toxicity in mice </plain></SENT>
<SENT sid="4" pm="."><plain>Toxicity was assessed by the general features of poisoning, electrocardiography (ECG), and levels of <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase (CK), <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH) and <z:chebi fb="1" ids="39124">calcium ions</z:chebi> (Ca(2+)) in cardiac tissues </plain></SENT>
<SENT sid="5" pm="."><plain>Toad Venom (90 mg/kg) caused <z:hpo ids='HP_0002179'>opisthotonus</z:hpo>, <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo>, and increases in cardiac levels of Ca(2+), CK and LDH </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with <z:e sem="disease" ids="C1321581" disease_type="Disease or Syndrome" abbrv="">Bezoar</z:e> Bovis (120, 240 and 480 mg/kg) significantly reduced the prevalence of <z:hpo ids='HP_0002179'>opisthotonus</z:hpo> and mortality, and prevented cardiotoxicity in CS-treated mice as evidenced by decreases in the scores of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and cardiac levels of CK, LDH and Ca(2+) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, and <z:chebi fb="5" ids="15891">taurine</z:chebi> derived from <z:e sem="disease" ids="C1321581" disease_type="Disease or Syndrome" abbrv="">Bezoar</z:e> Bovis offered marked protection against the <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> induced by CS or bufalin in vivo and in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>An anti-inflammatory study showed that <z:e sem="disease" ids="C1321581" disease_type="Disease or Syndrome" abbrv="">Bezoar</z:e> Bovis did not compromise the anti-inflammatory activity of Toad Venom on concanavalin-A (ConA)-stimulated proliferation of human peripheral blood mononuclear cells </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggested that <z:e sem="disease" ids="C1321581" disease_type="Disease or Syndrome" abbrv="">Bezoar</z:e> Bovis elicited protective and anti-arrhythmic effects against Toad Venom intoxication in mice, and is a novel <z:chebi fb="183" ids="50247">antidote</z:chebi> in combination with Toad Venom therapy </plain></SENT>
</text></document>